September 19 - 21, 2012    Washington DC , USA
Research of the molecular mechanisms of cancer, which is a complex disease, has benefitted from advances in “omic” and cellular technologies, offering new opportunities for diagnostic and therapeutic development. The Translational Cancer Medicine track of ADAPT 2012 Congress focuses on the innovation in non-invasive diagnostics for cancer (including CTCs, circulating proteins and microRNA, and exosomes), advances in clinical genomics, and advances in targeted therapies.

Topics include:

Circulating tumor cells as markers for disease prognosis and treatment selection
New targets and biomarkers derived from the cancer genome research
Cancer stem cells as targets and biomarkers in new therapy development
Case studies in cancer-targeted therapies
Novel non-invasive diagnostics for cancer

Venue

Location: Renaissance Washington D C Hotel Downtown
Contact 999 Ninth St NW. Washington , USA

Related events

CHI’S Translational Cancer Medicine September 19 - 21, 2012
CHI’S Translational Cancer Medicine September 24 - 25, 2011
CHI’S Translational Cancer Medicine September 13 - 16, 2010
CHI’S Translational Cancer Medicine 15 January, 2010
CHI’S Translational Cancer Medicine January 26 - 28, 2009